Profil
Stephen Vogt is currently the President of Provectus LLC.
Previously, in 2014, he worked as the Director & Vice President at Intelligent Living America, Inc.
Postes actifs de Stephen Vogt
| Sociétés | Poste | Début |
|---|---|---|
Provectus LLC
 Provectus LLC Information Technology ServicesTechnology Services Part of Intelligent Living America, Inc., Provectus LLC is a clinical-stage biotechnology company based in Miami, FL. The company develops immunotherapy medicines for different diseases using halogenated xanthenes. Provectus's lead molecule is named Rose Bengal Sodium (RBS), which is the active pharmaceutical ingredient in the drug product candidates of the company's clinical development programs and preclinical formulations of the drug discovery programs. The pharmaceutical-grade RBS displays different therapeutic effects at different concentrations and can be formulated for delivery by different routes of administration. Lee Joshua Eikov has been the CEO of the company since 2014. | President | - |
Anciens postes connus de Stephen Vogt
| Sociétés | Poste | Fin |
|---|---|---|
| INTT LIVI | Directeur/Membre du Conseil | 20/10/2014 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Intelligent Living America, Inc.
 Intelligent Living America, Inc. Information Technology ServicesTechnology Services Intelligent Living America, Inc. is a holding company, which engages in the provision of cognitive exercise, brain training games, and alternative wellness products and services. It specializes in the acquisition and integration of information technology, cloud technology service, Internet, and web technologies. The company was founded in 2000 and is headquartered in Coral Gables, FL. | Technology Services |
Provectus LLC
Provectus LLC Information Technology ServicesTechnology Services Part of Intelligent Living America, Inc., Provectus LLC is a clinical-stage biotechnology company based in Miami, FL. The company develops immunotherapy medicines for different diseases using halogenated xanthenes. Provectus's lead molecule is named Rose Bengal Sodium (RBS), which is the active pharmaceutical ingredient in the drug product candidates of the company's clinical development programs and preclinical formulations of the drug discovery programs. The pharmaceutical-grade RBS displays different therapeutic effects at different concentrations and can be formulated for delivery by different routes of administration. Lee Joshua Eikov has been the CEO of the company since 2014. | Technology Services |
